Anna Lembke
#35,539
Most Influential Person Now
American psychiatrist and opioid researcher
Anna Lembke's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Anna Lembke Influential?
(Suggest an Edit or Addition)According to Wikipedia, Anna Lembke is an American psychiatrist who is Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic at Stanford University. She is a specialist in the opioid epidemic in the United States, and the author of Drug Dealer, MD, How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop. Her latest book, a New York Times bestseller, Dopamine Nation: Finding Balance in the Age of Indulgence, was released in August 2021.
Anna Lembke's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- HPA Axis in Major Depression: Cortisol, Clinical Symptomatology, and Genetic Variation Predict Cognition (2016) (405)
- Impaired recognition of facial emotion in mania. (2002) (276)
- A Prospective Trial of Modafinil as an Adjunctive Treatment of Major Depression (2004) (137)
- Distribution of Opioids by Different Types of Medicare Prescribers. (2016) (125)
- HPA Axis Genetic Variation, Cortisol, and Psychosis in Major Depression (2013) (101)
- Our Other Prescription Drug Problem. (2018) (101)
- Why doctors prescribe opioids to known opioid abusers. (2012) (96)
- Forum77: An Analysis of an Online Health Forum Dedicated to Addiction Recovery (2015) (93)
- Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol. (2014) (83)
- Time to Abandon the Self-Medication Hypothesis in Patients with Psychiatric Disorders (2012) (77)
- Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission (2022) (69)
- Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers. (2013) (66)
- Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period (2018) (49)
- The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary–adrenal activity in humans with psychotic major depression (2013) (46)
- Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification. (2016) (45)
- Recovery-oriented policy and care systems in the UK and USA. (2014) (44)
- Assessment of provider attitudes toward #naloxone on Twitter. (2016) (44)
- Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy. (2018) (42)
- Use of Opioid Agonist Therapy for Medicare Patients in 2013. (2016) (36)
- Depression in individuals with epilepsy (2000) (35)
- Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration (2013) (34)
- Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It's So Hard to Stop (2016) (32)
- Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression (2013) (32)
- Weighing the Risks and Benefits of Chronic Opioid Therapy. (2016) (31)
- Alcohol Screening Scores and the Risk of New-Onset Gastrointestinal Illness or Related Hospitalization (2011) (28)
- Psychosocial Service Utilization by Patients with Bipolar Disorders: Data from the First 500 Participants in the Systematic Treatment Enhancement Program (2004) (27)
- Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine (2019) (26)
- Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment. (2019) (24)
- Patterns of Opioid and Benzodiazepine Use in Opioid-Naïve Patients with Newly Diagnosed Low Back and Lower Extremity Pain (2019) (19)
- Depression and smoking cessation: Does the evidence support psychiatric practice? (2007) (18)
- Safety of antidepressants in the elderly (2003) (18)
- Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder. (2006) (17)
- Extended treatment for cigarette smoking cessation: a randomized control trial (2017) (17)
- The Opioid Epidemic as a Watershed Moment for Physician Training in Addiction Medicine (2018) (16)
- Buprenorphine Induction Without Opioid Withdrawal: A Case Series of 15 Opioid-Dependent Inpatients Induced on Buprenorphine Using Microdoses of Transdermal Buprenorphine. (2019) (16)
- A systematic review of stigma interventions for providers who treat patients with substance use disorders. (2021) (14)
- Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence (2016) (13)
- A call to include people with mental illness and substance use disorders alongside ‘regular’ smokers in smoking cessation research (2015) (12)
- Update on augmentation of antidepressant response in resistant depression (2005) (11)
- Current Status of the Utilization of Antiepileptic Treatments in Mood, Anxiety and Aggression: Drugs and Devices (2004) (11)
- Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders. (2002) (11)
- Risk of future trauma based on alcohol screening scores: A two-year prospective cohort study among US veterans (2012) (9)
- Tapering Long-Term Opioid Therapy. (2020) (8)
- Optimal Dosing of Lithium, Valproic Acid, and Lamotrigine in the Treatment of Mood Disorders (2009) (7)
- The status of evidence-based guidelines and algorithms in the treatment of depression (2002) (7)
- Tapering Patients Off of Benzodiazepines. (2017) (7)
- A qualitative study of treatment-seeking heroin users in contemporary China (2015) (7)
- The relationships of positive and negative symptoms with neuropsychological functioning and their ability to predict verbal memory in psychotic major depression (2012) (7)
- Moderation Management: A Mutual-Help Organization for Problem Drinkers Who Are Not Alcohol-Dependent (2012) (6)
- From self-medication to intoxication: time for a paradigm shift. (2013) (6)
- A telehealth inpatient addiction consult service is both feasible and effective in reducing readmission rates. (2022) (5)
- What self-help organizations tell us about the syndrome model of addiction. (2012) (4)
- Unsafe Supply: Why Making Controlled Prescription Drugs Available for Unsupervised Use Will Not Target the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19-- A Commentary on Bonn et al. (2020). (2020) (4)
- Why doctors prescribe opioids to known opioid abusers. How cultural attitudes and financial disincentives affect the prescribing habits of physicians. (2013) (3)
- Online mutual-help intervention for reducing heavy alcohol use (2020) (3)
- Gabapentin dependence and withdrawal requiring an 18-month taper in a patient with alcohol use disorder: a case report (2021) (2)
- Self-Help Organizations for Substance Use Disorders (2016) (2)
- Substance Use Among Older Adults: Ethical Issues. (2019) (2)
- Introduction Why Is This Special Issue on Women’s Professional Development in Psychiatry Necessary? (2004) (2)
- Relapse on ketamine followed by severe and prolonged withdrawal: A cautionary case and review of potential medical therapies (2017) (2)
- Clinical management of alcohol use disorders in the neurology clinic. (2014) (2)
- Qualitative Assessment of Clerkship Students’ Perspectives of the Topics of Pain and Addiction in their Preclinical Curriculum (2018) (2)
- TREATMENT OF MOOD DISORDERS: A SURPRISING OMISSION, AND THE ROLE OF LAMOTRIGINE AS A PROTOTYPICAL BIPOLAR ANTIDEPRESSANT (2010) (1)
- 276. Impaired facial fear recognition in manic but not euthymic bipolar patients (2000) (1)
- A Day in the Life of an Academic Psychiatrist (2003) (1)
- Buprenorphine for Long-Term Chronic Pain Management: Still Looking for the Evidence (2020) (0)
- A Letter From the Foreign Legion (1996) (0)
- Review of a Randomized-Controlled Trial of Adjunctive Bupropion in the Treatment of SSRI-Induced Sexual Dysfunction (2007) (0)
- Why doctors prescribe opioids to known opioid abusers. (2013) (0)
- Psychotic Major Depression : Phenomenology and the Pursuit of Optimal Treatment (2008) (0)
- A piece of my mind. A letter from the foreign legion. (1996) (0)
- Diagnosis, Development, and Treatment of Substance Use Disorders among Adolescents and Young Adults (2011) (0)
- Qualitative exploration of the psychological dimensions of telehealth shared medical appointments (SMAs) for buprenorphine prescribing. (2022) (0)
- List of Contributors (2019) (0)
- Examining gender differences in opioid, benzodiazepine, and antibiotic prescribing (2019) (0)
- A Friday in the life of an academic psychiatrist. (2003) (0)
- Faculty Opinions recommendation of Drug policy and the public good: evidence for effective interventions. (2012) (0)
- How Healers Became Dealers (2019) (0)
- Antidepressant interventions in the HPA system (2008) (0)
- AUDIT-C Scores Predict Gastrointestinal Disorders: Variations by Sex and Age: (621302010-001) (2010) (0)
- Buprenorphine Microdosing Cross Tapers: A Time for Change (2022) (0)
This paper list is powered by the following services:
Other Resources About Anna Lembke
What Schools Are Affiliated With Anna Lembke?
Anna Lembke is affiliated with the following schools:
